Alembic Pharmaceuticals Limited (NSE:APLLTD)
912.10
-19.15 (-2.06%)
Mar 28, 2025, 3:30 PM IST
Alembic Pharmaceuticals Revenue
Alembic Pharmaceuticals had revenue of 16.93B INR in the quarter ending December 31, 2024, with 3.81% growth. This brings the company's revenue in the last twelve months to 64.19B, up 4.93% year-over-year. In the fiscal year ending March 31, 2024, Alembic Pharmaceuticals had annual revenue of 62.29B with 10.19% growth.
Revenue (ttm)
64.19B
Revenue Growth
+4.93%
P/S Ratio
2.85
Revenue / Employee
4.32M
Employees
14,858
Market Cap
182.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 62.29B | 5.76B | 10.19% |
Mar 31, 2023 | 56.53B | 3.47B | 6.54% |
Mar 31, 2022 | 53.06B | -873.40M | -1.62% |
Mar 31, 2021 | 53.93B | 7.87B | 17.10% |
Mar 31, 2020 | 46.06B | 6.71B | 17.06% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |
Alembic Pharmaceuticals News
- 7 days ago - Pharma and hospital stocks in focus today: Alembic Pharma, Gland Pharma, Apollo Hospital, Fortis Healthcare, Dr Reddy’s [March 24, 2025] - Business Upturn
- 7 days ago - Top stocks to watch today, March 24: Alembic Pharma, Godrej Properties, NCC, Adani Green, Reliance Industries and more - Business Upturn
- 9 days ago - Alembic Pharmaceuticals completes USFDA inspection at Karakhadi API-III facility with zero observations - Business Upturn
- 13 days ago - JSW Energy, Coffee Day, Alembic Pharma, Zota Health Care among stocks to watch today in business expansions - Business Upturn
- 21 days ago - Alembic Pharma shares drop 2.6% after US FDA issues one observation for Vadodara unit - Business Upturn
- 24 days ago - Alembic Pharmaceuticals receives form 483 with one procedural observation after US FDA inspection at Vadodara facility - Business Upturn
- 6 weeks ago - Stocks to watch today: M&M, BHEL, Zydus Life, Alembic Pharma, and PCBL in focus on Feb 17, 2025 - Business Upturn
- 2 months ago - Alembic Pharmaceuticals receives USFDA approval for Brexpiprazole tablets - Business Upturn